Two Sigma Investments LP Reduces Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Two Sigma Investments LP decreased its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 23.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 193,980 shares of the company's stock after selling 58,860 shares during the period. Two Sigma Investments LP owned about 0.52% of Crescent Capital BDC worth $3,728,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of CCAP. Montag A & Associates Inc. bought a new position in Crescent Capital BDC in the 4th quarter worth $35,000. C M Bidwell & Associates Ltd. purchased a new stake in Crescent Capital BDC in the 4th quarter worth about $39,000. Aquatic Capital Management LLC purchased a new stake in Crescent Capital BDC in the 4th quarter worth about $129,000. Generation Capital Management LLC bought a new position in Crescent Capital BDC in the 4th quarter worth about $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Crescent Capital BDC in the 4th quarter worth about $218,000. Institutional investors own 49.46% of the company's stock.

Analyst Upgrades and Downgrades

CCAP has been the subject of several recent analyst reports. Wall Street Zen downgraded shares of Crescent Capital BDC from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Wells Fargo & Company cut their price objective on shares of Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating for the company in a report on Friday, May 16th. Raymond James cut their target price on shares of Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Finally, Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and cut their target price for the stock from $18.50 to $17.00 in a research note on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, Crescent Capital BDC presently has a consensus rating of "Hold" and an average target price of $17.60.

Crescent Capital BDC Trading Up 0.6%

NASDAQ:CCAP traded up $0.09 on Friday, hitting $15.44. The stock had a trading volume of 176,483 shares, compared to its average volume of 136,040. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The stock has a market cap of $572.21 million, a price-to-earnings ratio of 7.76 and a beta of 0.63. The company has a fifty day moving average price of $15.79 and a two-hundred day moving average price of $17.88. Crescent Capital BDC, Inc. has a 1-year low of $13.54 and a 1-year high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The company had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. Equities research analysts expect that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Monday, June 30th will be issued a dividend of $0.42 per share. The ex-dividend date is Monday, June 30th. This represents a $1.68 dividend on an annualized basis and a yield of 10.88%. Crescent Capital BDC's dividend payout ratio (DPR) is presently 125.37%.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.